Cecropin-melittin and lactoferricin peptides killed multi-drug resistant Salmonella in standard tests but could not reach bacteria hiding inside cells.
64 µM MICagainst multi-drug resistant Salmonella, but zero intracellular killing effectiveness
What the researchers found
Both antimicrobial peptides showed clear antibacterial activity against three field strains of multi-drug resistant S. Enteritidis in standard lab tests. Minimum inhibitory concentrations (MIC) were 64 micromolar, and minimum bactericidal concentrations (MBC) were 128-256 micromolar, meaning the kill dose was 2-4 times the growth-stopping dose.
The peptides were stable across a range of conditions: high temperatures (70-90 degrees C), protease exposure (trypsin, proteinase K, lysozyme), varying salt concentrations, and pH range of 4.0 to 8.0. They did not damage red blood cells, showed minimal toxicity to RAW 264.7 macrophage and HEp-2 cells, and were safe for beneficial gut bacteria (L. acidophilus and L. rhamnosus).
The problem: once S. Enteritidis invaded immune cells (RAW 264.7 macrophages), neither peptide could kill it. They showed bacteriostatic (growth-stopping) effects in macrophages but no significant bactericidal (killing) effect in either cell line (P > 0.05).
Why it matters
Antibiotic-resistant Salmonella is a growing public health threat. Antimicrobial peptides are a promising alternative because bacteria rarely develop resistance to them. This study shows these two peptides are effective and safe in solution but reveals a critical limitation: they cannot reach bacteria hiding inside cells. This means they would need to be combined with cell-penetrating strategies to be truly useful.
The numbers in context
MIC 64µM; MBC 128-256µM; non-hemolytic; no significant intracellular killing (P>0.05)
How the study worked
Tested in lab dishes (in vitro). MIC and MBC determined against three multi-drug resistant S. Enteritidis field strains. Stability tested under heat, protease, salt, and pH stress. Safety evaluated via hemolysis assay on sheep red blood cells, cytotoxicity in RAW 264.7 and HEp-2 cells, and effects on beneficial Lactobacillus species. Intracellular killing tested by infecting cells with bacteria, then treating with peptides and counting surviving bacteria over time.
Who was studied
Three field strains of multi-drug resistant S. Enteritidis; RAW 264.7 and HEp-2 cell lines
What this study cannot tell us
Tested only in lab dishes, not in animals or humans. The three S. Enteritidis strains may not represent all resistant variants. The failure to kill intracellular bacteria is a major functional limitation. MIC/MBC values of 64-256 micromolar are relatively high compared to some other AMPs, raising questions about practical dosing.
How to read the evidence
Preliminary evidence from lab tests only. The critical failure to kill intracellular bacteria limits practical relevance.
When this study was published
Published in 2020. The challenge of intracellular peptide delivery remains an active area of research.
The bigger picture
Antibiotic-resistant Salmonella is a growing public health threat. While antimicrobial peptides are promising alternatives, this study highlights a critical gap: killing bacteria in a test tube is not enough if the peptides cannot reach intracellular infections where Salmonella hides and multiplies.
Questions still open
- Could cell-penetrating peptide conjugation help these AMPs reach intracellular Salmonella?
- Are there other antimicrobial peptides that can kill intracellular bacteria?
- What modifications would improve intracellular activity while maintaining safety?
Common questions
Why can't these peptides kill Salmonella inside cells?
Are antimicrobial peptides a replacement for antibiotics?
Read the original research
Antimicrobial efficacy of Cecropin A (1-7)- Melittin and Lactoferricin (17-30) against multi-drug resistant Salmonella Enteritidis.
Microbial pathogenesis, 147, 104405
Citation
Gourkhede, Diksha P; Bhoomika, Sirsant; Pathak, Richa; Yadav, Jay Prakash; Nishanth, Dani; Vergis, Jess; Malik, S V S; Barbuddhe, S B; Rawool, D B. (2020). Antimicrobial efficacy of Cecropin A (1-7)- Melittin and Lactoferricin (17-30) against multi-drug resistant Salmonella Enteritidis.. Microbial pathogenesis, 147, 104405. https://doi.org/10.1016/j.micpath.2020.104405